Skip to main content
Amy Johnson, MD, Oncology, Cleveland, OH

AmyJohnsonMD

Oncology Cleveland, OH

Cutaneous Lymphoma

Physician

Dr. Johnson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Johnson's full profile

Already have an account?

  • Office

    xxx
    Cleveland, OH 44106

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Dermatology, 2024 - 2027
  • University Hospitals
    University HospitalsFellowship, 2020 - 2023
  • Ohio State University
    Ohio State UniversityFellowship, Cutaneous Lymphomas, 2019 - 2020
  • Indiana University School of Medicine/Ball Memorial
    Indiana University School of Medicine/Ball MemorialResidency, Internal Medicine, 2018 - 2019
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2018
  • University of Missouri-Kansas City
    University of Missouri-Kansas CityB.S., Major: Biology; Minor: Chemistry, Summa Cum Laude, 2014

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2024 - 2026
  • IN State Medical License
    IN State Medical License 2018 - 2025
  • MO State Medical License
    MO State Medical License 2024 - 2025
  • OH State Medical License
    OH State Medical License 2019 - 2025
  • NE State Medical License
    NE State Medical License 2024 - 2024

Awards, Honors, & Recognition

  • Certification in Basic Quality and Safety 2018
  • Joseph Hurley, MD scholarship 2016
  • Fellow Phi Kappa Phi, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Topical imiquimod monotherapy for indolent primary cutaneous B‐cell lymphomas: a single‐institution experience  
    Hwang S, Johnson A, Fabbro S, Hastings J, et. al, British Journal of Dermatology, 8/1/2020
  • Psychology Dramatized: Shutter Island Film Analysis  
    Amy G. Johnson and Dr. Melisa Rempfer, Journal of Psychological Inquiry, 1/1/2013

Abstracts/Posters

  • Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...
    Amy Johnson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Oncology fellows’ knowledge and current practice regarding outpatient oncology and palliative care. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Resolving ethical conflicts in health care: Consult case regarding medical futility, surrogate decision making. 
    1/1/2018
  • Polypodium Leucotomos- Why Not? 
    University of Missouri - 1/1/2017
  • Join now to see all

Other

  • Honors Scholar Thesis: Implications of beta-hydroxy- beta-methylbutyrate Supplementation on Expression of Key Regulatory Genes during C2C12 Myoblast Differentiation. 
    Amy G. Johnson and Dr. Marco Brotto, PhD, BSN
    University of Missouri- Kansas City - 1/1/2014

Grant Support

  • Development of predictive psoriasis response endotypes using single cell transcriptomics in ustekinumab responders versus non-respondersLEO Foundation ($558,000)2022–2024
  • Correlation between clinical markers and transcriptome analyses in psoriasis patients.National Psoriasis Foundation ($50,000)2021–2022